Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma

Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study

“…Several other studies examining the effect of anti-VEGF on NVG patients found no statistically significant change between trabeculectomy with anti-VEGF to trabeculectomy with MMC or 5-FU. 16,26–32 The success rates of those studies were lower (between 50% and 80% for all groups); however, for cases of NVG, an additional benefit favoring intracameral anti-VEGF was rapid regression of iris neovascularization. 26–28…”

Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study

“…Several other studies examining the effect of anti-VEGF on NVG patients found no statistically significant change between trabeculectomy with anti-VEGF to trabeculectomy with MMC or 5-FU. 16,26–32 The success rates of those studies were lower (between 50% and 80% for all groups); however, for cases of NVG, an additional benefit favoring intracameral anti-VEGF was rapid regression of iris neovascularization. 26–28…”

Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence

“…Another study performed by Ozsutcu et al evaluated the use of an intraoperative bevacizumab injection, with the same dosage, associated with pterygium excision with rotational conjunctival flap followed by another injection after 1 week, reporting significantly less recurrence than rotational flap alone [30]. No side effects related to bevacizumab injection were observed in any previous study [31–33]. …”

Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage

“…However, SO tamponade may lead to the elevation of IOP, which probably result in irreversible loss of vision. Marey et al [ 29 ] reported the effect of preoperative IVB injection before trabeculectomy for NVG. The results showed that the mean preoperative IOP dropped from 41.45 ± 5.89 mmHg to 19.3 ± 5.5 mmHg and 17.75 ± 3.74 mmHg at 6 months and 12 months postoperatively, respectively.…”

Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study

“…Several other studies examining the effect of anti-VEGF on NVG patients found no statistically significant change between trabeculectomy with anti-VEGF to trabeculectomy with MMC or 5-FU. 16,26–32 The success rates of those studies were lower (between 50% and 80% for all groups); however, for cases of NVG, an additional benefit favoring intracameral anti-VEGF was rapid regression of iris neovascularization. 26–28…”

Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence

“…Another study performed by Ozsutcu et al evaluated the use of an intraoperative bevacizumab injection, with the same dosage, associated with pterygium excision with rotational conjunctival flap followed by another injection after 1 week, reporting significantly less recurrence than rotational flap alone [30]. No side effects related to bevacizumab injection were observed in any previous study [31–33]. …”

Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage

“…However, SO tamponade may lead to the elevation of IOP, which probably result in irreversible loss of vision. Marey et al [ 29 ] reported the effect of preoperative IVB injection before trabeculectomy for NVG. The results showed that the mean preoperative IOP dropped from 41.45 ± 5.89 mmHg to 19.3 ± 5.5 mmHg and 17.75 ± 3.74 mmHg at 6 months and 12 months postoperatively, respectively.…”

Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study

“…Several other studies examining the effect of anti-VEGF on NVG patients found no statistically significant change between trabeculectomy with anti-VEGF to trabeculectomy with MMC or 5-FU. 16,26–32 The success rates of those studies were lower (between 50% and 80% for all groups); however, for cases of NVG, an additional benefit favoring intracameral anti-VEGF was rapid regression of iris neovascularization. 26–28…”

Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence

“…Another study performed by Ozsutcu et al evaluated the use of an intraoperative bevacizumab injection, with the same dosage, associated with pterygium excision with rotational conjunctival flap followed by another injection after 1 week, reporting significantly less recurrence than rotational flap alone [30]. No side effects related to bevacizumab injection were observed in any previous study [31–33]. …”

Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage

“…However, SO tamponade may lead to the elevation of IOP, which probably result in irreversible loss of vision. Marey et al [ 29 ] reported the effect of preoperative IVB injection before trabeculectomy for NVG. The results showed that the mean preoperative IOP dropped from 41.45 ± 5.89 mmHg to 19.3 ± 5.5 mmHg and 17.75 ± 3.74 mmHg at 6 months and 12 months postoperatively, respectively.…”